Mayumi Nagata Selected Research

Mayumi Nagata Research Topics

Disease

9	Psoriasis (Pustulosis Palmaris et Plantaris) 11/2022 - 03/2018
7	Atopic Dermatitis (Atopic Eczema) 09/2021 - 06/2019
4	Chromosome Aberrations (Chromosome Abnormalities) 04/2015 - 08/2012
2	Alopecia Areata 09/2021 - 06/2019
2	Psoriatic Arthritis 02/2020 - 01/2020
2	Cataract (Cataracts) 09/2009 - 09/2008
2	Capsule Opacification 09/2009 - 03/2008
1	COVID-19 06/2022
1	Paronychia 01/2022
1	Ingrown Nails (Ingrown Nail) 01/2022
1	Pyogenic Granuloma 01/2022
1	Obesity 11/2021
1	Noncommunicable Diseases 11/2021
1	Body Weight (Weight, Body) 11/2021
1	Fever (Fevers) 05/2021
1	Melanoma (Melanoma, Malignant) 05/2021
1	Herpes Zoster 04/2021
1	Neuralgia (Stump Neuralgia) 04/2021
1	Inflammation (Inflammations) 10/2020
1	Eczema 09/2020
1	Conjunctivitis 01/2020
1	Infections 03/2018
1	Pain (Aches) 02/2015
1	Lichen Planus (Lichen Ruber Planus) 02/2013
1	Thymoma (Thymic Carcinoma) 02/2013
1	Inappropriate ADH Syndrome (SIADH) 12/2002
1	Arthritis (Polyarthritis) 12/2002
1	Rheumatoid Arthritis 12/2002

Drug/Important Bio-Agent (IBA)

5	dupilumabIBA 02/2021 - 06/2019
4	carbendazimIBA 04/2015 - 08/2012
4	Colchicine FDA LinkGeneric 04/2015 - 08/2012
4	Diethylnitrosamine (N-Nitrosodiethylamine)IBA 04/2015 - 08/2012
4	1,2-Dimethylhydrazine (1,2 Dimethylhydrazine)IBA 04/2015 - 08/2012
3	Capsules (Microcapsules)IBA 09/2009 - 03/2008
2	ixekizumabIBA 11/2022 - 01/2020
2	Biological ProductsIBA 06/2022 - 03/2008
2	Biomarkers (Surrogate Marker)IBA 04/2021 - 10/2020
2	Chemokine CCL17IBA 10/2020 - 01/2020
1	ErbB Receptors (EGF Receptor)IBA 01/2022
1	Fatty Acids (Saturated Fatty Acids)IBA 11/2021
1	Glucose (Dextrose)FDA LinkGeneric 11/2021
1	LipidsIBA 11/2021
1	hederageninIBA 11/2021
1	Apolipoprotein B-48IBA 11/2021
1	AntioxidantsIBA 11/2021
1	Triglycerides (Triacylglycerol)IBA 11/2021
1	ChylomicronsIBA 11/2021
1	Staphylococcal Protein A (Protein A)IBA 11/2021
1	SaponinsIBA 11/2021
1	PowdersIBA 11/2021
1	baricitinibIBA 09/2021
1	encorafenibIBA 05/2021
1	fibrin fragment D (D-dimer)IBA 05/2021
1	edoxabanIBA 05/2021
1	trametinibIBA 05/2021
1	dabrafenibIBA 05/2021
1	binimetinibIBA 05/2021
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 05/2021
1	Interleukin-10 (Interleukin 10)IBA 04/2021
1	ChemokinesIBA 10/2020
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 09/2020
1	Messenger RNA (mRNA)IBA 08/2020
1	Thyrotropin (Thyroid-Stimulating Hormone)FDA Link 02/2020
1	C-Reactive ProteinIBA 02/2020
1	Triiodothyronine (Liothyronine)FDA LinkGeneric 02/2020
1	Thyroxine (Levothyroxine)FDA LinkGeneric 02/2020
1	Infliximab (Remicade)FDA Link 01/2020
1	Immunoglobulin E (IgE)IBA 01/2020
1	apremilastIBA 06/2019
1	brodalumabIBA 03/2018
1	Pharmaceutical PreparationsIBA 02/2015
1	Buprenorphine (Subutex)FDA LinkGeneric 02/2015
1	Analgesics (Analgesic Drugs)IBA 02/2015
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 02/2015
1	Etretinate FDA Link 02/2013
1	mizoribineIBA 12/2002
1	Vasopressins (Vasopressin)IBA 12/2002

Therapy/Procedure

4	Hepatectomy 04/2015 - 08/2012
2	Intraocular Lenses (Intraocular Lens) 09/2008 - 03/2008
1	Blood Component Removal (Apheresis) 11/2022
1	Critical Care (Surgical Intensive Care) 06/2022
1	Therapeutics 05/2021